Quality View on Injectable Product Considerations (20of35) Complex Generic Drugs – Sep. 25-26, 2019 скачать в хорошем качестве

Quality View on Injectable Product Considerations (20of35) Complex Generic Drugs – Sep. 25-26, 2019

Bita Mirzai-Azarm from CDER’s Office of Pharmaceutical Quality discusses critical attributes of injectable combination products including functionality attributes and quality attributes. She also provides points-to-consider for frequently asked questions. Learn more at https://www.fda.gov/drugs/cder-small-... _______________________________ FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research. Visit https://www.fda.gov/cdersbia and https://www.fda.gov/cdersbialearn for news and a repository of training activities. Email: CDERSBIA@fda.hhs.gov Phone: (301) 796-6707 I (866) 405-5367 LinkedIn:   / cder-small-business-and-industry-assistance   Twitter:   / fda_drug_info   CDER small business e-mail update subscription: https://updates.fda.gov/subscriptionm...